KR101109043B1 - 각질세포 또는 혈청 유래의 아토피성 피부질환 마커 - Google Patents
각질세포 또는 혈청 유래의 아토피성 피부질환 마커 Download PDFInfo
- Publication number
- KR101109043B1 KR101109043B1 KR1020080136673A KR20080136673A KR101109043B1 KR 101109043 B1 KR101109043 B1 KR 101109043B1 KR 1020080136673 A KR1020080136673 A KR 1020080136673A KR 20080136673 A KR20080136673 A KR 20080136673A KR 101109043 B1 KR101109043 B1 KR 101109043B1
- Authority
- KR
- South Korea
- Prior art keywords
- geneid
- expression level
- sample
- candidate
- gene
- Prior art date
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Urology & Nephrology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Gene name | Accession no. | OMIM no. | Intensity* | AD type |
INOSITOL POLYPHOSPHATE-1-PHOSPHATASE (INPP1) | L08488 | 147263 | 2.92 | ADi |
HUMAN CEREBELLAR DEGENERATION-ASSOCIATED PROTEIN (RPS15A) | M16965 | - | 2.61; 1.1 | ADe; ADi |
CHEMOKINE, C MOTIF, LIGAND 1 (XCL1) | NM_002995 | 600250 | 2.46; 1.26 | ADe; ADi |
ACTIVIN A RECEPTOR, TYPE IB (ACVR1B) | Z22536 | 601300 | 2.29 | ADi |
COMPLEMENT COMPONENT 6 DEFICIENCY (C6) | J05064 | 217050 | 2.13 | ADe |
TRANSKETOLASE-LIKE 1 (TKTL1) | X91817 | 300044 | 1.89; 1.05 | ADe; ADi |
SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 3 (STAT3) | AJ012463 | 102582 | 1.89 | ADi |
HYPOXIA UP-REGULATED 1 (HYOU1) | U65785 | 601746 | 1.83; 1.38 | ADe; ADi |
PHOSPHATASE, PROSTATE-SPECIFIC ACID (ACPP) | AA613916 | 171790 | 1.7 | ADi |
MATRIX METALLOPROTEINASE 19 (MMP19) | U37791 | 601807 | 1.67 | ADi |
FIBROBLAST GROWTH FACTOR RECEPTOR 4 (FGFR4) | NM_002011 | 134935 | 1.65 | ADi |
HOMEOBOX B2 (HOXB2) | X16665 | 142967 | 1.62 | ADe |
MIXED-LINEAGE LEUKEMIA 5 (MLL5) | AA460875 | 608444 | 1.61; 1.61 | ADe; ADi |
ZINC FINGER PROTEIN, SUBFAMILY 1A, MEMBER 1 (ZNFN1A1) | AI378126 | 603023 | 1.5 | ADe |
CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 9 (CYP2C9) | M61857 | 601130 | 1.48 | ADe |
MOTILIN (MLN) | NM_002418 | 158270 | 1.48 | ADe |
STABILIN 1 (STAB1) | NM_015136 | 608560 | 1.45 | ADe |
STRATAGENE LUNG CARCINOMA 937218 (ATP9A) | AA620508 | - | 1.45; 1.07 | ADe; ADi |
TROPHININ-ASSOCIATED PROTEIN (TROAP) | U04810 | 603872 | 1.44; 1.06 | ADe; ADi |
VIMENTIN (VIM) | X56134 | 193060 | 1.42 | ADe |
HISTATIN 3 (HTN3) | M26665 | 142702 | 1.41 | ADi |
SEC10, S. CEREVISIAE, HOMOLOG-LIKE 1 (SEC10L1) | AL045563 | 604469 | 1.40 | ADi |
COLLAGEN, TYPE IX, ALPHA-1 (COL9A1) | AW022764 | 120210 | 1.39 | ADe |
SOARES INFANT BRAIN 1NIB (CAPNS2) | T78374 | - | 1.38 | ADe |
SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY A, MEMBER 3 (SMARCA3) | AI459249 | 603257 | 1.37 | ADi |
NEOGENIN (NEO1) | U61262 | 601907 | 1.37; 1.52 | ADe; ADi |
UNC5, C. ELEGANS, HOMOLOG OF, B (UNC5B) | AA846091 | 607870 | 1.37; 2.34 | ADe; ADi |
FERRITIN HEAVY CHAIN 1 (FTH1) | AA102267 | 134770 | 1.36 | ADe |
WEE 1 TYROSINE KINASE (WEE1) | U10564 | 193525 | 1.35 | ADe |
PROTEASE, SERINE, 12 (PRSS12) | AJ001531 | 606709 | 1.33 | ADi |
ABL INTERACTOR 2 (ABI2) | AF260261 | 606442 | 1.32 | ADi |
FIBROBLAST GROWTH FACTOR 13 (FGF13) | AF100143 | 300070 | 1.31 | ADe |
NEBULIN (NEB) | X83957 | 161650 | 1.31 | ADe |
CUTANEOUS T-CELL LYMPHOMA-ASSOCIATED ANTIGEN 5 (CTAGE5) | AA446039 | 602132 | 1.3 | ADe |
KIAA0378 GENE (CAST) | AB002376 | - | 1.29; 1.07 | ADe; ADi |
PROTEIN KINASE C, EPSILON (PRKCE) | AA683420 | 176975 | 1.29; 1.1 | ADe; ADi |
URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 2 FAMILY, MEMBER B17 (UGT2B17) | U59209 | 601903 | 1.28 | ADi |
TENASCIN C (TNC) | X56160 | 187380 | 1.27 | ADe |
KILLER CELL LECTIN-LIKE RECEPTOR, SUBFAMILY B, MEMBER 1 (KLRB1) | U11276 | 602890 | 1.26; 1.27 | ADe; ADi |
POTASSIUM CHANNEL, VOLTAGE-GATED, ISK-RELATED SUBFAMILY, MEMBER 4 (KCNE4) | AA058640 | 607775 | 1.26 | ADi |
OCCLUDIN (OCLN) | U49184 | 602876 | 1.25 | ADe |
MATRIX METALLOPROTEINASE 1 (MMP1) | M13509 | 120353 | 1.25 | ADi |
PREGNANCY ZONE PROTEIN (PZP) | X54380 | 176420 | 1.23; 1.12 | ADe; ADi |
INTERLEUKIN 13 RECEPTOR, ALPHA-2 (IL13RA2) | R52795 | 300130 | 1.22; 1.16 | ADe; ADi |
ZINC FINGER PROTEIN 161 (ZNF161) | AA195154 | 606747 | 1.21 | ADi |
THYMOCYTE ANTIGEN CD1D (CD1D) | NM_001766 | 188410 | 1.19; 1.08 | ADe; ADi |
EPIREGULIN (EREG) | D30783 | 602061 | 1.19 | ADi |
ANTITHROMBIN III DEFICIENCY (SERPINC1) | NM_000488 | 107300 | 1.18; 1.28 | ADe;ADi |
WW DOMAIN-CONTAINING BINDING PROTEIN 4 (WBP4) | AF071185 | 604981 | 1.17; 1.14 | ADe;ADi |
INTEGRIN, BETA-3 (ITGB3) | M35999 | 173470 | 1.16 | ADi |
CLIP-ASSOCIATED PROTEIN 1 (CLASP1) | AB014522 | 605852 | 1.16 | ADi |
ZONA-PELLUCIDA-BINDING PROTEIN (ZPBP) | D17570 | - | 1.16 | ADi |
A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 2 (ADAM2) | AA399579 | 601533 | 1.14 | ADe |
NPC1 GENE (NPC1) | AI001914 | 607623 | 1.14 | ADe |
SOARES INFANT BRAIN 1NIB (PTP9Q22) | H16415 | - | 1.14 | ADe |
MATRIX METALLOPROTEINASE 10 (MMP10) | X07820 | 185260 | 1.14 | ADi |
CHITINASE 3-LIKE 2 (CHI3L2) | U58515 | 601526 | 1.13 | ADe |
CARBOHYDRATE SULFOTRANSFERASE 1 (CHST1) | U65637 | 603797 | 1.13 | ADe |
GLUTAMINE:FRUCTOSE-6-PHOSPHATE AMIDOTRANSFERASE 1 (GFPT1) | M90516 | 138292 | 1.1 | ADe |
LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN, TYPE 3 (CD58) | Y00636 | 153420 | 1.1; 1.06 | ADe; ADi |
MYOSIN IE (MYO1E) | U14391 | 601479 | 1.1 | ADe |
HOMO SAPIENS CILIARY NEUROTROPHIC FACTOR (CNTF) | NM_000614 | - | 1.1 | ADe |
COCHLIN (COCH) | AF006740 | 603196 | 1.1 | ADi |
PHOSPHATIDYLSERINE RECEPTOR (PTDSR) | AB011157 | 604914 | 1.09 | ADe |
CYSTEINE-RICH, ANGIOGENIC INDUCER, 61 (CYR61) | Y12084 | 602369 | 1.09 | ADe |
MELANOMA ANTIGEN, FAMILY A, 1 (MAGEA1) | NM_004988 | 300016 | 1.08 | ADe |
SIN3-ASSOCIATED POLYPEPTIDE, 30-KD (SAP30) | AI372048 | 603378 | 1.08 | ADi |
E1A-BINDING PROTEIN, 400-KD (EP400) | AI143868 | 606265 | 1.08 | ADi |
CYTOPLASMIC TYROSINE KINASE (CSK) | X60114 | 124095 | 1.07 | ADe |
CYTOCHROME P450, SUBFAMILY IIB, POLYPEPTIDE 6 (CYP2B6) | M29874 | 123930 | 1.07 | ADe |
NUCLEAR FACTOR OF ACTIVATED T CELLS, CYTOPLASMIC, CALCINEURIN-DEPENDENT 4 (NFATC4) | L41066 | 602699 | 1.07 | ADi |
PROTEASE INHIBITOR 5 (SERPINB5) | AA316156 | 154790 | 1.05 | ADe |
GUANYLATE CYCLASE 1, SOLUBLE, ALPHA-2 (GUCY1A2) | X63282 | 601244 | 1.05 | ADe |
ARMADILLO REPEAT GENE DELETES IN VELOCARDIOFACIAL SYNDROME (ARVCF) | U51269 | 602269 | 1.05 | ADi |
INTERCELLULAR ADHESION MOLECULE 2 (ICAM2) | NM_000873 | 146630 | 1.04 | ADe |
BONE MORPHOGENETIC PROTEIN 4 (BMP4) | NM_001202 | 112262 | 1.03 | ADe |
ATAXIN 1 (SCA1) | NM_000332 | 601556 | 1.03 | ADe |
HOMEODOMAIN-INTERACTING PROTEIN KINASE 1 (HIPK1) | AI761800 | 608003 | 1.03 | ADe |
ACIDIC EPIDIDYMAL GLYCOPROTEIN-LIKE 1 (CRISP1) | X95237 | 601193 | 1.03 | ADe |
CD6 ANTIGEN (CD6) | BC033755 | 186720 | 1.03 | ADi |
SOARES INFANT BRAIN 1NIB (MGC10854) | R17445 | - | 1.02 | ADe |
FIBRINOGEN, B BETA POLYPEPTIDE (FGB) | AI769452 | 134830 | 1.02 | ADe |
PANTOTHENATE KINASE 3 (PANK3) | AI002941 | 606161 | 1.02 | ADe |
PLATELET FACTOR 4, VARIANT 1 (PF4V1) | NM_002620 | 173461 | 1.01 | ADe |
DNAJ, E. COLI, HOMOLOG OF, SUBFAMILY C, MEMBER 3 (DNAJC3) | AI652089 | 601184 | 1.01; 1.42 | ADe; ADi |
RAS HOMOLOG GENE FAMILY, MEMBER Q (RHOQ) | AA043151 | 605857 | 1.01 | ADi |
UNCHARACTRIZED BONE MARROW PROTEIN BM031 (CPVL) | AF217508 | - | 1.01 | ADi |
INOSITOL 1,4,5-TRISPHOSPHATE 3-KINASE A (ITPKA) | X54938 | 147521 | 1.01 | ADi |
PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-BINDING PROTEIN (PPARBP) | Y13467 | 604311 | 1.00 | ADe |
Gene name | Accession no. | OMIM no. | Intensity* | AD type |
FAS-ACTIVATED SERINE/THREONINE KINASE (FASTK) | AI126915 | 606965 | -1.01 | ADe |
PROSPERO-RELATED HOMEOBOX 1 (PROX1) | U44060 | 601546 | -1.01 | ADe |
MACROPHAGE SCAVENGER RECEPTOR (MSR1) | D13264 | 153622 | -1.01 | ADe |
APOLIPOPROTEIN D (APOD) | AI188519 | 107740 | -1.01 | ADi |
EGF-LIKE MODULE-CONTAINING, MUCIN-LIKE HORMONE RECEPTOR 2 (EMR2) | AK024426 | 606100 | -1.02 | ADe |
HUMAN CISPLATIN RESISTANCE ASSOCIATED BETA PROTEIN (CRA) | U78557 | - | -1.02 | ADi |
RNA-BINDING PROTEIN GENE WITH MULTIPLE SPLICING (RBPMS) | D84110 | 601558 | -1.02 | ADi |
ISL1 TRANSCRIPTION FACTOR, LIM/HOMEODOMAIN (ISL1) | U07559 | 600366 | -1.03 | ADe |
VG5Q GENE (HSU84971) | U84971 | 608464 | -1.03 | ADi |
SOLUTE CARRIER FAMILY 26, MEMBER 11 (SLC26A11) | AI417381 | 610117 | -1.03 | ADi |
MYXOVIRUS RESISTANCE 1, MOUSE, HOMOLOG OF (MX1) | AA477235 | 147150 | -1.04 | ADe |
ERYTHROCYTE SURFACE PROTEIN BAND 7.2 (EPB72) | NM_004099 | 133090 | -1.04 | ADi |
GASTRULATION BRAIN HOMEOBOX 2 (GBX2) | AA933790 | 601135 | -1.05 | ADe |
HUNTINGTIN-INTERACTING PROTEIN 12 (HIP1R) | AB014555 | 605613 | -1.05 | ADe |
CALCITONIN RECEPTOR-LIKE GENE (CALCRL) | U17473 | 114190 | -1.05 | ADi |
INTERFERON REGULATORY FACTOR 9 (ISGF3G) | M87503 | 147574 | -1.05 | ADi |
PHOSPHODIESTERASE 6A, cGMP-SPECIFIC, ROD, ALPHA (PDE6A) | M26061 | 180071 | -1.07 | ADi |
NATRIURETIC PEPTIDE RECEPTOR A/GUANYLATE CYCLASE A (NPR1) | AI676183 | 108960 | -1.08 | ADi |
A-KINASE ANCHOR PROTEIN 13 (AKAP13) | AI674926 | 604686 | -1.08 | ADi |
NUCLEOLAR AND COILED-BODY PHOSPHOPROTEIN 1 (NOLC1) | Z34289 | 602394 | -1.08 | ADi |
VAV2 ONCOGENE (VAV2) | AL045952 | 600428 | -1.09 | ADi |
F-BOX AND LEUCINE-RICH REPEAT PROTEIN 5 (FBXL5) | AI347306 | 605655 | -1.09 | ADi |
ACYL-CoA OXIDASE 3, PRISTANOYL (ACOX3) | Y11411 | 603402 | -1.10 | ADe |
CYCLIN-DEPENDENT KINASE 3 (CDK3) | X66357 | 123828 | -1.10 | ADi |
PROLIFERATION-RELATED Ki-67 ANTIGEN (MKI67) | X65550 | 176741 | -1.11 | ADe |
MOTHERS AGAINST DECAPENTAPLEGIC, DROSOPHILA, HOMOLOG OF, 5 (SMAD5) | NM_005903 | 603110 | -1.11; -1.44 | ADe; ADi |
DYSTROBREVIN, ALPHA (DTNA) | U46744 | 601239 | -1.13 | ADe |
PHOSPHOLIPID SCRAMBLASE 1 (PLSCR1) | AB006746 | 604170 | -1.13 | ADe |
CHEMOKINE (C-X3-C MOTIF) RECEPTOR 1 (CX3CR1) | U20350 | 601470 | -1.13 | ADi |
PLATELET-DERIVED GROWTH FACTOR RECEPTOR, ALPHA (PDGFRA) | M21574 | 173490 | -1.14 | ADi |
CUG TRIPLET REPEAT, RNA-BINDING PROTEIN 1 (CUGBP1) | AI018596 | 601074 | -1.20 | ADi |
ACYL-CoA DEHYDROGENASE, SHORT/BRANCHED CHAIN (ACADSB) | BC013756 | 600301 | -1.21 | ADe |
ALPHA-2-MACROGLOBULIN (A2M) | M11313 | 103950 | -1.22 | ADe |
NATRIURETIC PEPTIDE PRECURSOR A (NPPA) | BC005893 | 108780 | -1.22; -1.1 | ADe; ADi |
CARNITINE ACETYLTRANSFERASE (CRAT) | X78706 | 600184 | -1.28 | ADi |
PROTEIN-TYROSINE PHOSPHATASE, RECEPTOR-TYPE, ALPHA (PTPRA) | AA701899 | 176884 | -1.29 | ADe |
BRCA1-ASSOCIATED RING DOMAIN 1 (BARD1) | U76638 | 601593 | -1.29 | ADe |
PCTAIRE PROTEIN KINASE 3 (PCTK3) | X66362 | 169190 | -1.29 | ADi |
THYMIDINE KINASE, SOLUBLE (TK1) | K02581 | 188300 | -1.30 | ADe |
PROTEASOME SUBUNIT, BETA-TYPE, 9 (PSMB9) | AI923532 | 177045 | -1.31 | ADe |
RECEPTOR-INTERACTING SERINE/THREONINE KINASE 1 (RIPK1) | U50062 | 603453 | -1.31 | ADi |
DACHSHUND, DROSOPHILA, HOMOLOG OF (DACH1) | AI650353 | 603803 | -1.32 | ADi |
X-RAY REPAIR COMPLEMENTING DEFECTIVE REPAIR IN CHINESE HAMSTER CELLS 4 (XRCC4) | AA909333 | 194363 | -1.32 | ADi |
NUCLEAR RECEPTOR SUBFAMILY 5, GROUP A, MEMBER 1 (NR5A1) | NM_004959 | 184757 | -1.33 | ADi |
NUCLEAR PROTEIN, ATAXIA-TELANGIECTASIA LOCUS (NPAT) | NM_002519 | 601448 | -1.38 | ADi |
KINESIN FAMILY MEMBER 5A (KIF5A) | AL118561 | 602821 | -1.39 | ADe |
RAN BINDING PROTEIN 6 (RANBP6) | AF039023 | - | -1.39 | ADi |
GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL D-ASPARTATE-LIKE 1A (GRINL1A) | AL050091 | 606485 | -1.40 | ADe |
ALANYL-tRNA SYNTHETASE (AARS) | D32050 | 601065 | -1.41 | ADe |
KIAA0312 GENE (UREB1) | AB002310 | - | -1.41 | ADi |
REGENERATING ISLET-DERIVED 1-ALPHA (REG1A) | M18963 | 167770 | -1.42 | ADe |
INTERFERON-INDUCED PROTEIN WITH TETRATRICOPEPTIDE REPEATS 1 (IFIT1) | M24594 | 147690 | -1.42 | ADi |
PARAOXONASE 3 (PON3) | AI074616 | 602720 | -1.47 | ADi |
TRANSFORMING GROWTH FACTOR, BETA RECEPTOR ASSOCIATED PROTEIN 1 (TGFBRAP1) | AF022795 | 606237 | -1.47 | ADi |
TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR 1C (TAF1C) | L39059 | 604905 | -1.50 | ADe |
NEURAL PRECURSOR CELL EXPRESSED, DEVELOPMENTALLY DOWNREGULATED 4 (NEDD4) | D42055 | 602278 | -1.54 | ADi |
ACTININ, ALPHA-4 (ACTN4) | AL047603 | 604638 | -1.55 | ADi |
CORONIN 2B (CORO2B) | AB023142 | 605002 | -1.57 | ADi |
ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE 1 (ENPP1) | M57736 | 173335 | -1.57 | ADi |
KINESIN FAMILY MEMBER 11 (KIF11) | X85137 | 148760 | -1.61 | ADi |
DNAJ, E. COLI, HOMOLOG OF, SUBFAMILY C, MEMBER 6 (DNAJC6) | AI753668 | 608375 | -1.71 | ADe |
PHOSPHATE REGULATING ENDOPEPTIDASE HOMOLOG, X-LINKED (PHEX) | NM_000444 | 307800 | -1.72 | ADi |
MATRIX METALLOPROTEINASE 11 (MMP11) | X57766 | 185261 | -1.81 | ADe |
TETRASPANIN 9 (TSPAN9) | AF089749 | - | -1.82 | ADi |
ATP-BINDING CASSETTE, SUBFAMILY 3, MEMBER 2 (ABCD2) | AJ000327 | 601081 | -1.90 | ADe |
ENDOTHELIAL DIFFERENTIATION GENE 6 (EDG6) | AJ000479 | 603751 | -2.13 | ADe |
GRINL1A COMPLEX LOCUS (GRINL1A) | AL050091 | 606485 | -2.16 | ADi |
PROTEOLIPID PROTEIN 1 (PLP1) | NM_000533 | 300401 | -2.23 | ADi |
Gene symbol | Gene name | Gene ID | Regulation | Prediction |
NEO1 | neogenin homolog 1 (chicken) | 4756 | Up | PSIMAP |
MYO1E | myosin IE | 4643 | Up | PSIMAP |
WEE1 | WEE1 homolog (S. pombe) | 7465 | Up | PSIMAP |
UNC5B | unc-5 homolog B (C. elegans) | 219699 | Up | PSIMAP |
CD58 | CD58 molecule | 965 | Up | PSIMAP |
CSK | c-src tyrosine kinase | 1445 | Up | PSIMAP/PEIMAP |
STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) | 6774 | Up | PSIMAP |
ICAM2 | intercellular adhesion molecule 2 | 3384 | Up | PSIMAP |
PRKCE | protein kinase C, epsilon | 5581 | Up | PSIMAP/ PEIMAP |
ACVR1B | activin A receptor, type IB | 91 | Up | PSIMAP |
FGFR4 | fibroblast growth factor receptor 4 | 2264 | Up | PSIMAP |
HIPK1 | homeodomain interacting protein kinase 1 | 204851 | Up | PSIMAP |
CD1D | CD1d molecule | 912 | Up | PSIMAP |
IL13RA2 | interleukin 13 receptor, alpha 2 | 3598 | Up | PSIMAP |
ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 3690 | Up | PEIMAP |
VAV2 | vav 2 guanine nucleotide exchange factor | 7410 | Down | PSIMAP |
BARD1 | BRCA1 associated RING domain 1 | 580 | Down | PSIMAP |
DNAJC6 | DnaJ (Hsp40) homolog, subfamily C, member 6 | 9829 | Down | PSIMAP |
RIPK1 | receptor (TNFRSF)-interacting serine-threonine kinase 1 | 8737 | Down | PSIMAP |
PCTK3 | PCTAIRE protein kinase 3 | 5129 | Down | PSIMAP |
NPR1 | natriuretic peptide receptor A/guanylate cyclase A (atrionatriuretic peptide receptor A) | 4881 | Down | PSIMAP |
PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 5156 | Down | PSIMAP |
CDK3 | cyclin-dependent kinase 3 | 1018 | Down | PSIMAP/PEIMAP |
MX1 | myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) | 4599 | Down | PSIMAP |
SMAD5 | SMAD family member 5 | 4090 | Down | PEIMAP |
Claims (10)
- NEO1(GeneID: 4756) 유전자로부터 얻어지는 mRNA에 상보적인 서열을 갖는 올리고뉴클레오타이드 프로브; 및상기 유전자에 의하여 코딩되는 단백질을 검출하기 위한 항체로 이루어진 군에서 선택된 1종 이상을 포함하는아토피성 피부질환 진단용 조성물.
- 제1항에 있어서, 상기 조성물은 추가적으로MMP1(GeneID: 4312), MMP10(GeneID: 4319), MYO1E(GeneID: 4643), WEE1(GeneID: 7465), UNC5B(GeneID: 219699), CD58(GeneID: 965), ACVR1B(GeneID: 91), FGFR4(GeneID: 2264), HIPK1(GeneID: 204851), IL13RA2(GeneID: 3598), ITGB3(GeneID: 3690), VAV2(GeneID: 7410), BARD1(GeneID: 580), DNAJC6(GeneID: 9829), RIPK1(GeneID: 8737), PCTK3(GeneID: 5129), NPR1(GeneID: 4881), PDGFRA(GeneID: 5156), CDK3(GeneID: 1018), MX1(GeneID: 4599) 및 SMAD5(GeneID: 4090)로 이루어진 군에서 선택된 1종 이상의 유전자로부터 얻어지는 mRNA에 상보적인 서열을 갖는 올리고뉴클레오타이드 프로브; 및상기 1종 이상의 유전자에 의하여 코딩되는 단백질을 검출하기 위한 항체로 이루어진 군에서 선택된 1종 이상을 포함하는아토피성 피부질환 진단용 조성물.
- 제1항 또는 제2항의 조성물을 포함하는 아토피성 피부질환 진단용 바이오칩.
- 아토피성 피부질환의 진단에 필요한 정보를 제공하기 위하여, 피검체로부터 얻은 시료에서 아토피성 피부질환 마커 NEO1(GeneID: 4756) 유전자의 발현 정도를 측정하여 이를 정상 개체에서의 해당 유전자의 발현 정도와 비교하는 단계를 포함하는, 아토피성 피부질환 마커를 검출하는 방법.
- 제4항에 있어서, 추가적으로피검체로부터 얻은 시료에서 MMP1(GeneID: 4312), MMP10(GeneID: 4319), MYO1E(GeneID: 4643), WEE1(GeneID: 7465), UNC5B(GeneID: 219699), CD58(GeneID: 965), ACVR1B(GeneID: 91), FGFR4(GeneID: 2264), HIPK1(GeneID: 204851), IL13RA2(GeneID: 3598), ITGB3(GeneID: 3690), VAV2(GeneID: 7410), BARD1(GeneID: 580), DNAJC6(GeneID: 9829), RIPK1(GeneID: 8737), PCTK3(GeneID: 5129), NPR1(GeneID: 4881), PDGFRA(GeneID: 5156), CDK3(GeneID: 1018), MX1(GeneID: 4599) 및 SMAD5(GeneID: 4090)로 이루어진 군에서 선택된 1종 이상의 아토피성 피부질환 마커 유전자의 발현 정도를 측정하여 이를 정상 개체에서의 해당 유전자의 발현 정도와 비교하는 단계를 포함하는,아토피성 피부질환 마커를 검출하는 방법.
- 제4항에 있어서, 상기 피검체로부터 얻은 시료는 각질세포 또는 혈청인아토피성 피부질환 마커를 검출하는 방법.
- 후보물질을 생검 시료와 접촉시키는 단계;상기 후보물질 접촉된 시료에서의 NEO1(GeneID: 4756) 유전자의 발현 정도를 측정하는 단계;상기 후보물질 접촉된 시료에서 측정된 발현 정도를 후보물질 접촉되지 않은 시료에서의 해당 유전자의 발현 정도와 비교하는 단계; 및상기 비교 결과 후보물질 접촉된 시료에서의 NEO1(GeneID: 4756) 의 발현 정도가 정상 개체와 비교하여 증가된 경우 상기 후보물질을 아토피성 피부질환 유발인자로 판단하는 단계를 포함하는 아토피성 피부질환 유발인자 탐색 방법.
- 제7항에 있어서, 추가적으로후보물질을 생검 시료와 접촉시키는 단계;상기 후보물질 접촉된 시료에서의 MMP1(GeneID: 4312), MMP10(GeneID: 4319), MYO1E(GeneID: 4643), WEE1(GeneID: 7465), UNC5B(GeneID: 219699), CD58(GeneID: 965), ACVR1B(GeneID: 91), FGFR4(GeneID: 2264), HIPK1(GeneID: 204851), IL13RA2(GeneID: 3598), ITGB3(GeneID: 3690), VAV2(GeneID: 7410), BARD1(GeneID: 580), DNAJC6(GeneID: 9829), RIPK1(GeneID: 8737), PCTK3(GeneID: 5129), NPR1(GeneID: 4881), PDGFRA(GeneID: 5156), CDK3(GeneID: 1018), MX1(GeneID: 4599) 및 SMAD5(GeneID: 4090)로 이루어진 군에서 선택된 1종 이상의 유전자의 발현 정도를 측정하는 단계;상기 후보물질 접촉된 시료에서 측정된 발현 정도를 후보물질 접촉되지 않은 시료에서의 해당 유전자의 발현 정도와 비교하는 단계; 및상기 비교 결과 후보물질 접촉된 시료에서의 MMP1(GeneID: 4312), MMP10(GeneID: 4319), MYO1E(GeneID: 4643), WEE1(GeneID: 7465), UNC5B(GeneID: 219699), CD58(GeneID: 965), ACVR1B(GeneID: 91), FGFR4(GeneID: 2264), HIPK1(GeneID: 204851), IL13RA2(GeneID: 3598) 및 ITGB3(GeneID: 3690)로 이루어진 군에서 선택된 1종 이상의 발현 정도가 정상 개체와 비교하여 증가된 경우, 또는 VAV2(GeneID: 7410), BARD1(GeneID: 580), DNAJC6(GeneID: 9829), RIPK1(GeneID: 8737), PCTK3(GeneID: 5129), NPR1(GeneID: 4881), PDGFRA(GeneID: 5156), CDK3(GeneID: 1018), MX1(GeneID: 4599) 및 SMAD5(GeneID: 4090)로 이루어진 군에서 선택된 1종 이상의 발현 정도가 정상 개체와 비교하여 감소된 경우, 상기 후보물질을 아토피성 피부질환 유발인자로 판단하는 단계를 포함하는 아토피성 피부질환 유발인자 탐색 방법.
- 후보물질을 아토피성 피부질환 환자로부터 얻은 시료와 접촉시키는 단계;상기 후보물질 접촉된 시료에서의 NEO1(GeneID: 4756) 의 발현 정도를 측정하는 단계;상기 후보물질 접촉된 아토피성 피부질환 환자의 시료에서 측정된 발현 정도를 후보물질 접촉되지 않은 아토피성 피부질환 환자의 시료에서의 해당 유전자의 발현 정도와 비교하는 단계; 및상기 비교 결과 후보물질 접촉된 시료에서의 NEO1(GeneID: 4756) 의 발현 정도가 후보물질 접촉되지 않은 시료에서의 해당 유전자의 발현 정도보다 감소된 경우 상기 후보물질을 아토피성 피부질환의 예방, 경감 또는 치료 물질로 판단하는 단계를 포함하는 아토피성 피부질환의 예방, 경감 또는 치료 물질의 탐색 방법.
- 제9항에 있어서, 추가적으로후보물질을 아토피성 피부질환 환자로부터 얻은 시료와 접촉시키는 단계;상기 후보물질 접촉된 시료에서의 MMP1(GeneID: 4312), MMP10(GeneID: 4319), MYO1E(GeneID: 4643), WEE1(GeneID: 7465), UNC5B(GeneID: 219699), CD58(GeneID: 965), ACVR1B(GeneID: 91), FGFR4(GeneID: 2264), HIPK1(GeneID: 204851), IL13RA2(GeneID: 3598), ITGB3(GeneID: 3690), VAV2(GeneID: 7410), BARD1(GeneID: 580), DNAJC6(GeneID: 9829), RIPK1(GeneID: 8737), PCTK3(GeneID: 5129), NPR1(GeneID: 4881), PDGFRA(GeneID: 5156), CDK3(GeneID: 1018), MX1(GeneID: 4599) 및 SMAD5(GeneID: 4090)로 이루어진 군에서 선택된 1종 이상의 발현 정도를 측정하는 단계;상기 후보물질 접촉된 아토피성 피부질환 환자의 시료에서 측정된 발현 정도를 후보물질 접촉되지 않은 아토피성 피부질환 환자의 시료에서의 해당 유전자의 발현 정도와 비교하는 단계; 및상기 비교 결과 후보물질 접촉된 시료에서의 MMP1(GeneID: 4312), MMP10(GeneID: 4319), MYO1E(GeneID: 4643), WEE1(GeneID: 7465), UNC5B(GeneID: 219699), CD58(GeneID: 965), ACVR1B(GeneID: 91), FGFR4(GeneID: 2264), HIPK1(GeneID: 204851), IL13RA2(GeneID: 3598) 및 ITGB3(GeneID: 3690)로 이루어진 군에서 선택된 1종 이상의 발현 정도가 후보물질 접촉되지 않은 시료에서의 해당 유전자의 발현 정도보다 감소된 경우, 또는 후보물질 접촉된 시료에서의 VAV2(GeneID: 7410), BARD1(GeneID: 580), DNAJC6(GeneID: 9829), RIPK1(GeneID: 8737), PCTK3(GeneID: 5129), NPR1(GeneID: 4881), PDGFRA(GeneID: 5156), CDK3(GeneID: 1018), MX1(GeneID: 4599) 및 SMAD5(GeneID: 4090)로 이루어진 군에서 선택된 1종 이상의 발현 정도가 후보물질 접촉되지 않은 시료에서의 해당 유전자의 발현 정도보다 증가된 경우, 상기 후보물질을 아토피성 피부질환의 예방 또는 치료 물질로 판단하는 단계를 포함하는 아토피성 피부질환의 예방, 경감 또는 치료 물질의 탐색 방법.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020080136673A KR101109043B1 (ko) | 2008-12-30 | 2008-12-30 | 각질세포 또는 혈청 유래의 아토피성 피부질환 마커 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020080136673A KR101109043B1 (ko) | 2008-12-30 | 2008-12-30 | 각질세포 또는 혈청 유래의 아토피성 피부질환 마커 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20100078416A KR20100078416A (ko) | 2010-07-08 |
KR101109043B1 true KR101109043B1 (ko) | 2012-02-09 |
Family
ID=42639632
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020080136673A KR101109043B1 (ko) | 2008-12-30 | 2008-12-30 | 각질세포 또는 혈청 유래의 아토피성 피부질환 마커 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101109043B1 (ko) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101818672B1 (ko) | 2017-02-17 | 2018-01-16 | 가천대학교 산학협력단 | 아토피 피부염 진단용 조성물 및 상기 조성물을 이용한 아토피 피부염의 진단 방법 |
KR101901365B1 (ko) | 2017-03-02 | 2018-09-28 | 재단법인 아산사회복지재단 | 장상피세포 내 특이적 발현 아토피피부염 유전자 ptgr2 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20050057525A (ko) * | 2002-09-20 | 2005-06-16 | 진링크 인코퍼레이티드 | 피부 건강을 평가하기 위한 키트 및 방법 |
KR20080063326A (ko) * | 2005-10-21 | 2008-07-03 | 가부시키가이샤환케루 | 아토피성 피부염 마커와 그의 이용기술 |
-
2008
- 2008-12-30 KR KR1020080136673A patent/KR101109043B1/ko active IP Right Grant
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20050057525A (ko) * | 2002-09-20 | 2005-06-16 | 진링크 인코퍼레이티드 | 피부 건강을 평가하기 위한 키트 및 방법 |
KR20080063326A (ko) * | 2005-10-21 | 2008-07-03 | 가부시키가이샤환케루 | 아토피성 피부염 마커와 그의 이용기술 |
Non-Patent Citations (1)
Title |
---|
Clinical and Experimental Allergy, Vol. 36, pp. 649-657 (2006.05.) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101818672B1 (ko) | 2017-02-17 | 2018-01-16 | 가천대학교 산학협력단 | 아토피 피부염 진단용 조성물 및 상기 조성물을 이용한 아토피 피부염의 진단 방법 |
KR101901365B1 (ko) | 2017-03-02 | 2018-09-28 | 재단법인 아산사회복지재단 | 장상피세포 내 특이적 발현 아토피피부염 유전자 ptgr2 |
Also Published As
Publication number | Publication date |
---|---|
KR20100078416A (ko) | 2010-07-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11111541B2 (en) | Diagnostic MiRNA markers for Parkinson's disease | |
Suzuki et al. | Gene expression profiling of human lymph node metastases and matched primary breast carcinomas: clinical implications | |
KR101652854B1 (ko) | 방광암 검출용 소변 표지 | |
EP2982985B1 (en) | System for predicting prognosis of locally advanced gastric cancer | |
Ma et al. | Serial analysis of gene expression in mouse uterus at the implantation site | |
WO2003060470A2 (en) | Breast cancer expression profiling | |
KR20080016789A (ko) | 혈액 림프구에서 자궁내막증을 진단할 수 있는 분자마커의동정 | |
EP2524051A2 (en) | Diagnostic gene expression platform | |
CN104968802B (zh) | 作为诊断标志物的新miRNA | |
US10604809B2 (en) | Methods and kits for the diagnosis and treatment of pancreatic cancer | |
US20110143946A1 (en) | Method for predicting the response of a tumor in a patient suffering from or at risk of developing recurrent gynecologic cancer towards a chemotherapeutic agent | |
JP2011525106A (ja) | 瀰漫性b大細胞型リンパ腫のマーカーおよびその使用方法 | |
US20050100933A1 (en) | Breast cancer survival and recurrence | |
WO2010088688A2 (en) | Diagnosis of in situ and invasive breast cancer | |
US20150344962A1 (en) | Methods for evaluating breast cancer prognosis | |
CN110418850A (zh) | 鉴定和使用小rna预测因子的方法 | |
KR20100058420A (ko) | 심근염 전사체 바이오마커 | |
KR101105811B1 (ko) | 외인성 아토피 피부염에 대한 바이오마커 | |
CN109022583A (zh) | hsa_circ_0021977在制备诊断乳腺癌产品上的应用 | |
KR101109043B1 (ko) | 각질세포 또는 혈청 유래의 아토피성 피부질환 마커 | |
JP2013510575A (ja) | 卵丘細胞が差示発現する遺伝子およびそれらを用いる妊娠受容能をもつ卵母細胞の同定のためのアッセイ | |
WO2014080060A1 (es) | Método para predecir la respuesta al tratamiento con quimioterapia en pacientes con cáncer | |
EP1683862A1 (en) | Microarray for assessing neuroblastoma prognosis and method of assessing neuroblastoma prognosis | |
Hughes et al. | DNA microarray-based transcriptomic profiling of an isogenic cell culture model of breast tumour cell invasion | |
KR20100045703A (ko) | 침윤성 또는 비침윤성 방광암의 예후 예측용 진단 키트, 방광암의 예후 측정방법 및 방광암 치료제의 스크리닝 방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20141212 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20151230 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20161220 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20171219 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20181226 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20191223 Year of fee payment: 9 |